Takanori Ito

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis <scp>C</scp> virus infection

Hidenori Toyoda, Takashi Kumada, Toshifumi Tada et al. · Journal of Gastroenterology and Hepatology · 2015 · 94 citations

Hepatitis B, Pathology, Cirrhosis +21

Proposal of diagnostic criteria of drug induced hepatic injury in DDW-J2004 workshop.

Hajime Takikawa, M Onji, Yoriyuki Takamori et al. · Kanzo · 2005 · 86 citations · Full text

Ddw-j2004 Workshop, Hepatic Disorders, Hepatology +13

Multifaceted Therapeutic Benefits of Factors Derived From Dental Pulp Stem Cells for Mouse Liver Fibrosis

Marina Hirata, Masatoshi Ishigami, Yoshihiro Matsushita et al. · Stem Cells Translational Medicine · 2016 · 83 citations · Full text

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Daniel Q. Huang, Andrew Tran, Ming‐Lun Yeh et al. · Hepatology · 2023 · 83 citations

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki et al. · Liver Cancer · 2023 · 80 citations · Full text